Bloodstream Infections - From Threats to Solutions

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to Bloodstream Infections - From Threats to Solutions

EF Hutton Starts Citius Pharmaceuticals (CTXR) at Buy

July 15, 2024 9:35 AM EDT

EF Hutton analyst Jason Kolbert initiates coverage on Citius Pharmaceuticals (NASDAQ: CTXR) with a Buy rating and a price target of $6.00.

The analyst comments "Low-Risk and High-Reward. Citius has two late-stage therapeutics, Mino-Lok (MLT) and LYMPHIR. Both products have demonstrated efficacy and safety and are in the final stages of the approval process.... More